{"product_id":"mapk1-mapk3-antibody-sc-f3509","title":"p44\/42 MAPK (Erk1\/2) Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003ep44\/42 MAPK (Erk1\/2) is a target of interest in many antibody-based workflows. Mitogen-activated protein kinases p42 and p44 (also known as Erk2 and Erk1) are critical mediators that relay signals from the cell surface to the nucleus. The p42\/p44 MAPK pathway transmits inputs from receptor tyrosine kinases, certain G protein-coupled receptors, cytokine receptors, and integrins via a Ras- Raf-MAP kinase kinase (MEK) -p42\/p44 MAPK activation cascade. Depending on the literature source, p44\/42 MAPK (Erk1\/2) may also be discussed as p44\/42 MAPK (Erk1\/2) and Mitogen-activated protein kinase 3.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell junction, cytoplasm, cytoskeleton, and membrane, which can matter when signal is compared across treatments or changing cell states. Following p44\/42 MAPK (Erk1\/2) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003ep44\/42 MAPK (Erk1\/2) is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell junction, cytoplasm, and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell junction, cytoplasm, and cytoskeleton across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for p44\/42 MAPK (Erk1\/2). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in p44\/42 MAPK (Erk1\/2) reflect biology rather than handling. When interpreting p44\/42 MAPK (Erk1\/2), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep p44\/42 MAPK (Erk1\/2) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578028007769,"sku":"F3509-20UL","price":139.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578028040537,"sku":"F3509-100UL","price":319.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578028073305,"sku":"F3509-2X100UL","price":479.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F3509-IF.png?v=1773601272","url":"https:\/\/absource.de\/products\/mapk1-mapk3-antibody-sc-f3509","provider":"Absource Diagnostics","version":"1.0","type":"link"}